Accident and emergency departments and outpatient clinics will be the first clinical settings to receive dedicated central funding for AI scribes this financial year, as NHS England moves to convert years of scattered local trials into a coordinated national programme. The money forms part of a wider push confirmed this month, with NHS England rolling out AI tools, including integrated ambient voice technology, backed by a £10 billion investment over the next three years.
The technology in question, known as ambient voice technology or AVT, listens to conversations between clinicians and patients and generates structured clinical notes automatically, reducing the time staff spend typing up records after each appointment. Trusts have been experimenting with various suppliers for more than a year, but the emphasis is now shifting decisively from evaluation to scale. Senior NHS digital executives have argued that the emphasis should now be on implementation and scaling, and they have urged for a stop to recurring AI experiments.
Because of their high patient traffic and stringent documentation requirements, A&E and outpatients are the parts of the medical system where AVT's productivity argument is most apparent, hence they were selected for the initial funding phase. Trial data has been central to that case. Recent trials at Great Ormond Street Hospital using ambient voice tools in A&E settings found a saving of £176 million in documentation time, unlocking an additional £658 million in capacity annually, with the potential to support an additional 3.4 million A&E attendances a year if the technology were scaled nationally. Separately, a major NHS England sponsored study found a 23.5 per cent increase in direct patient interaction time during appointments, alongside an 8.2 per cent reduction in overall appointment length, when AI scribes were used.
Funding guidance is expected to favour suppliers whose products integrate directly with existing electronic patient record systems over standalone software, a principle NHS England has already signalled in its wider technology strategy. That preference is already shaping procurement on the ground. The St George's, Epsom and St Helier, Croydon, Kingston, and Richmond trusts in southwest London are implementing a rollout that integrates with the Oracle Cerner Millennium digital patient record platform shared by the four trusts. This will allow clinical notes to be entered directly into patient records, with a goal of onboarding 10,000 clinicians in the first year and scaling to 20,000 over the course of four years. Hertfordshire Community NHS Trust has taken a similar path outside acute care, with more than 1,000 clinicians gaining access to the technology under a three-year contract expected to support around 250,000 appointments annually.
Deployment under the new funding is expected to begin within the current financial year, with trusts required to draw from NHS England's supplier registry rather than a single centralised framework. Procurement will be carried out by individual NHS bodies in accordance with their own governance processes, and NHS England does not endorse any of the suppliers on the registry. That structure places the burden of due diligence, contracting and clinical safety assurance on individual trusts and integrated care boards, even as central money accelerates the pace of adoption.
Evidence on the technology's real-world impact is still developing. A national evaluation led by the NIHR Rapid Service Evaluation Team has found that while adoption is accelerating, robust evidence on what AVT actually delivers remains limited, with measures of staff wellbeing, patient experience and system-level cost rarely assessed in a standardised way. The next phase of that evaluation will examine not only whether the technology saves time, but how it reshapes clinical work and whether the promised benefits hold up at scale.
For NHS leaders, the funding announcement marks a shift from asking whether AI scribes work to asking how quickly they can be embedded across the service without repeating the fragmented procurement patterns that have characterised digital adoption elsewhere in the NHS.
